Differential Influence of Diabetes Mellitus on Increased Jeopardized Myocardium After Initial Angioplasty or Bypass Surgery
Open Access
- 23 April 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (16) , 1914-1920
- https://doi.org/10.1161/01.cir.0000014967.78190.bb
Abstract
Background — Data are absent that compare midterm angiographic outcome between patients with and without diabetes after initial percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft surgery (CABG). Importantly, diabetes mellitus may differentially influence long-term survival after PTCA or CABG. Methods and Results — Patients with multivessel coronary disease who were previously enrolled in the Bypass Angiopathy Revascularization Investigation to compare initial PTCA versus CABG (n=1829) and who had a reduction in jeopardized myocardium after initial revascularization and at least 1 angiogram during 5-year follow-up were analyzed (n=897). This included 369 CABG-treated patients (16% with diabetes) and 528 PTCA-treated patients (18% with diabetes). The influence of diabetes on angiographic increase in percentage of jeopardized myocardium after initial revascularization with either PTCA or CABG was investigated. Among PTCA patients, the mean percentage increase in total jeopardized myocardium was significantly greater in those with diabetes than in those without at 1-year protocol-directed angiography (42% versus 24%, P =0.05) and on the first clinically performed (unscheduled) angiogram within 30 months (63% versus 50%, P =0.01) but not at 5-year protocol-directed angiography (34% versus 26%, P =0.33). This excess midterm risk associated with diabetes persisted after statistical adjustment. In contrast, among CABG patients, diabetes was not associated with percentage increase in jeopardized myocardium at any angiographic follow-up interval. Conclusions — Presence of diabetes differentially influences worsening of jeopardized myocardium after initial PTCA compared with CABG. This differential effect occurs irrespective of whether follow-up angiography is undertaken for clinical or nonclinical purposes.Keywords
This publication has 15 references indexed in Scilit:
- New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic studyJournal of the American College of Cardiology, 2001
- Management of coronary artery disease: therapeutic options in patients with diabetesJournal of the American College of Cardiology, 2000
- Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center Registry)The American Journal of Cardiology, 2000
- Practice still makes perfectAmerican Heart Journal, 1999
- Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass graftingThe Lancet, 1998
- Long-Term Angiographic Follow-Up of Coronary Balloon Angioplasty in Patients With Diabetes Mellitus: A Clue to the Explanation of the Results of the BARI StudyJournal of the American College of Cardiology, 1997
- Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I)The American Journal of Cardiology, 1997
- HEART DISEASE IN DIABETES MELLITUSEndocrinology and Metabolism Clinics of North America, 1996
- Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS)Journal of the American College of Cardiology, 1993
- Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 yearsThe American Journal of Medicine, 1980